bioRxiv Science⌕ Search

Biology subjects

Hawgood, S. B.

Publications and source records attributed to Hawgood, S. B..

2 recordsLinked to original sources

KLF4 promotes a KRT13+ hillock-like state in squamous lung cancer

Lung squamous cell carcinoma (LUSC) is a basal-like subtype of lung cancer with limited treatment options. While prior studies have identified tumour-propagating cell states in squamous tumours, the broader landscape of intra-tumoural heterogeneity within LUSC remains poorly understood. Here, we employ Sox2-driven mouse models, organoid cultures, and single-cell transcriptomic analyses to uncover previously unrecognized levels of cell fate diversity within LUSC. Specifically, we identify a KRT13+ hillock-like population of slower-dividing tumour cells characterized by immunomodulatory gene expression signatures. The tumour hillock-like state is conserved across multiple animal and human-derived models and is present in the majority of human LUSCs as well as head and neck and esophageal squamous tumours. Our findings shed light on the cellular origins of tumour hillock-like states: lung club cells give rise to tumours with luminal hillock-like populations, while basal-like tumour-propagating cells transition into basal hillock-like states, resembling lineage plasticity trajectories of the normal lung. Mechanistically, KLF4 promotes KRT13, a broadly conserved hillock-like state with enrichment of potential therapeutic targets, and resistance to platinum-based chemotherapy. Together, these results provide molecular insights into the lineage plasticity underlying intra-tumoural heterogeneity within LUSC, offering potential avenues for new therapeutic strategies.

cancer biology↗

Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer

Summary paragraphNeuroendocrine and tuft cells are rare, chemosensory epithelial lineages defined by expression of ASCL1 and POU2F3 transcription factors, respectively1,2. Neuroendocrine cancers, including small cell lung cancer (SCLC), frequently display tuft-like subsets, a feature linked to poor patient outcomes3-13. The mechanisms driving neuroendocrine-tuft tumour heterogeneity, and the origins of tuft-like cancers are unknown. Using multiple genetically-engineered animal models of SCLC, we demonstrate that a basal cell of origin (but not the accepted neuroendocrine origin) generates neuroendocrine-tuft-like tumours that highly recapitulate human SCLC. Single-cell clonal analyses of basal-derived SCLC further uncovers unexpected transcriptional states and lineage trajectories underlying neuroendocrine-tuft plasticity. Uniquely in basal cells, introduction of genetic alterations enriched in human tuft-like SCLC, including high MYC, PTEN loss, and ASCL1 suppression, cooperate to promote tuft-like tumours. Transcriptomics of 944 human SCLCs reveal a basal-like subset and a tuft-ionocyte-like state that altogether demonstrate remarkable conservation between cancer states and normal basal cell injury response mechanisms14-18. Together, these data suggest that the basal cell is a plausible origin for SCLC and other neuroendocrine-tuft cancers that can explain neuroendocrine-tuft heterogeneity--offering new insights for targeting lineage plasticity.

cancer biology↗